110 related articles for article (PubMed ID: 513839)
1. Combined treatment with hemoperfusion and hemodialysis in patients with chronic uremia.
Trznadel K; Kidawa Z; Luciak M; Madry K; Lutz W
Mater Med Pol; 1979; 11(2):167-72. PubMed ID: 513839
[No Abstract] [Full Text] [Related]
2. Comparative studies on the effect of hemoperfusion and hemodialysis on the elimination of some uremic toxins.
Trznadel K; Walasek L; Kidawa Z; Lutz W
Clin Nephrol; 1978 Dec; 10(6):229-31. PubMed ID: 729215
[TBL] [Abstract][Full Text] [Related]
3. [Use of hemosorption and hemodialysis in the treatment of chronic renal failure].
Riabov SI; Shostka GD; Lukichev BG; Strelko VV; Spiridonov VN
Ter Arkh; 1981; 53(6):15-21. PubMed ID: 7281026
[No Abstract] [Full Text] [Related]
4. Hemoperfusion for uremia: past, present, and future.
Winchester JF; Ash SR
Kidney Int Suppl; 1985 Dec; 17():S127-30. PubMed ID: 3867782
[No Abstract] [Full Text] [Related]
5. [Effect of hemodialysis and hemosorption on blood serum level of medium-molecular components in patients with chronic renal failure].
Kozlov VV; Riabov SI; Dorofeeva TB; von Appen K; Spiridonov VN
Ter Arkh; 1984; 56(7):77-81. PubMed ID: 6484840
[No Abstract] [Full Text] [Related]
6. Chronic renal disease patients with severe star fruit poisoning: hemoperfusion may be an effective alternative therapy.
Chen LL; Fang JT; Lin JL
Clin Toxicol (Phila); 2005; 43(3):197-9. PubMed ID: 15902795
[TBL] [Abstract][Full Text] [Related]
7. [Electromyography in patients in the terminal stages of chronic renal failure treated with regular hemodialysis and hemosorption].
Ender LA; Lagutina TS; Cherniakov VL; Shcherbakova EO; Shcherbakov VA
Urol Nefrol (Mosk); 1984; (5):57-62. PubMed ID: 6095507
[No Abstract] [Full Text] [Related]
8. [Use of enterodesis in the complex treatment of patients with pronounced chronic renal failure].
Del'machinskiĭ BV; Ermolenko VM; Lifshits NL; Suzdaleva VV; Makarova NL
Ter Arkh; 1988; 60(8):89-91. PubMed ID: 3227485
[No Abstract] [Full Text] [Related]
9. Combined hemodialysis-hemoperfusion treatment reduces the time of substitutive therapy in chronic uremia.
Stefoni S; Feliciangeli G; Coli L; Scolari MP; Bonomini V
Int J Artif Organs; 1981 Jul; 4(4):186-91. PubMed ID: 7327760
[TBL] [Abstract][Full Text] [Related]
10. [Chronic kidney failure: problems of pathogenesis and treatment].
Ermolenko VM
Ter Arkh; 1982; 54(7):114-8. PubMed ID: 6753210
[No Abstract] [Full Text] [Related]
11. [Possibilities of hemosorption for increasing the effectiveness of treatment of patients with renal tuberculosis with chronic renal insufficiency].
Strel'nikova VA; Mochalova TP
Probl Tuberk; 1985; (9):48-50. PubMed ID: 4070221
[No Abstract] [Full Text] [Related]
12. [The effect of hemodialysis on neutrophil enzyme activity in patients with uremia].
Moshchin'skiĭ P; Sydor A; Slovin'ski S
Lab Delo; 1991; (2):21-3. PubMed ID: 1709978
[TBL] [Abstract][Full Text] [Related]
13. [Blood viscosity and the erythrocyte charge in patients with chronic kidney failure and suppurative intoxication and during the correction of these conditions by hemosorption and hemodialysis].
Samoĭlov MV; Zakharchenko VN; Larionov SM; Naumov AG; Danilkov AP; Zakharova VD; Ivleva AI; Kudriavtsev IuV; Surikova TP
Urol Nefrol (Mosk); 1993; (4):34-7. PubMed ID: 8310565
[TBL] [Abstract][Full Text] [Related]
14. Effect of blood purification on plasma levels of intact parathyroid hormone in patients with chronic renal failure.
Liu J; Liu ZQ; Tao HQ
Di Yi Jun Yi Da Xue Xue Bao; 2004 Feb; 24(2):234-5. PubMed ID: 14965840
[TBL] [Abstract][Full Text] [Related]
15. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
16. Forces determining selection of uremia therapy.
Friedman EA; Lundin AP
Adv Nephrol Necker Hosp; 1984; 13():151-62. PubMed ID: 6433665
[No Abstract] [Full Text] [Related]
17. [Hemosorption as a treatment method for uremic complications].
Pilotovich VS; Ostapenko VA; Shilaĭ LM; Kirkovskiĭ VV; Nikolaĭchik VV
Klin Med (Mosk); 1982 Apr; 60(4):77-80. PubMed ID: 7098397
[No Abstract] [Full Text] [Related]
18. [Effect of hemosorption on uremic polyneuropathy].
Riabov SI; Shostka GD; Lukichev BG; Spiridonov VN; Strelko VV
Urol Nefrol (Mosk); 1981; (1):59-61. PubMed ID: 6259797
[No Abstract] [Full Text] [Related]
19. [The evaluation of the efficacy of efferent therapy in patients with acute and chronic kidney failure by the spectrum of blood middle-molecule fractions].
Kon'kova TA; Chudnovskaia MV; Golovanov SA
Urol Nefrol (Mosk); 1994; (4):35-7. PubMed ID: 7985299
[TBL] [Abstract][Full Text] [Related]
20. Preliminary report on the efficiency of combined haemodialysis-haemoperfusion treatment in chronic uraemia.
Albertazzi A; Cappelli P; Di Paolo B; Evangelista M
Life Support Syst; 1984; 2(4):245-51. PubMed ID: 6527556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
